• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

他汀类药物与β受体阻滞剂联合治疗对急性心肌梗死合并心力衰竭患者一年发病率和死亡率的影响。

Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure.

作者信息

Hognestad Aina, Dickstein Kenneth, Myhre Eivind, Snapinn Steven, Kjekshus John

机构信息

Department of Cardiology, Rikshospitalet, University of Oslo, Oslo, Norway.

出版信息

Am J Cardiol. 2004 Mar 1;93(5):603-6. doi: 10.1016/j.amjcard.2003.11.027.

DOI:10.1016/j.amjcard.2003.11.027
PMID:14996587
Abstract

This retrospective, nonrandomized analysis evaluated the effect of initiating statin or beta-blocker treatment early in the course of heart failure developed during acute myocardial infarction compared with the effect of neither or both treatments. Early initiation of statins or beta blockers alone was associated with improved event-free survival, and the benefits of the combined treatment were additive.

摘要

这项回顾性、非随机分析评估了在急性心肌梗死期间发生的心力衰竭病程早期开始使用他汀类药物或β受体阻滞剂治疗的效果，并与不进行任何治疗或同时进行两种治疗的效果进行了比较。单独早期开始使用他汀类药物或β受体阻滞剂与无事件生存期的改善相关，联合治疗的益处具有累加性。

相似文献

1
Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure.他汀类药物与β受体阻滞剂联合治疗对急性心肌梗死合并心力衰竭患者一年发病率和死亡率的影响。
Am J Cardiol. 2004 Mar 1;93(5):603-6. doi: 10.1016/j.amjcard.2003.11.027.
2
Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.阿司匹林、血管紧张素转换酶抑制剂和他汀类药物联合二级预防治疗对接受β受体阻滞剂治疗的急性心肌梗死患者 1 年死亡率的影响。支持复方药物治疗方法。
Curr Med Res Opin. 2011 Aug;27(8):1563-70. doi: 10.1185/03007995.2011.590969. Epub 2011 Jun 17.
3
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).在急性心肌梗死后出现左心室收缩功能障碍、心力衰竭或两者皆有的老年患者中，尽管接受了卡托普利和/或缬沙坦治疗，其死亡率和发病率仍然很高：缬沙坦急性心肌梗死试验（VALIANT）的结果。
Circulation. 2005 Nov 29;112(22):3391-9. doi: 10.1161/CIRCULATIONAHA.105.551143. Epub 2005 Nov 21.
4
[Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].[β受体阻滞剂与血管紧张素转换酶抑制剂联合治疗对急性心肌梗死后1年生存率的影响：PRIAMHO-II注册研究结果]
Rev Esp Cardiol. 2006 Apr;59(4):313-20.
5
Statin use and survival outcomes in elderly patients with heart failure.老年心力衰竭患者使用他汀类药物与生存结局
Arch Intern Med. 2005 Jan 10;165(1):62-7. doi: 10.1001/archinte.165.1.62.
6
Impact of medication therapy discontinuation on mortality after myocardial infarction.心肌梗死后药物治疗中断对死亡率的影响。
Arch Intern Med. 2006 Sep 25;166(17):1842-7. doi: 10.1001/archinte.166.17.1842.
7
Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure.他汀类药物治疗与心力衰竭患者心血管结局的改善及炎症标志物水平的降低相关。
J Card Fail. 2005 Oct;11(8):607-12. doi: 10.1016/j.cardfail.2005.05.011.
8
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).心肌梗死后高危患者中β受体阻滞剂联合卡托普利和/或缬沙坦的有效性（来自缬沙坦治疗急性心肌梗死[VALIANT]试验）
Am J Cardiol. 2009 Jul 15;104(2):151-7. doi: 10.1016/j.amjcard.2009.03.020. Epub 2009 Jun 3.
9
Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction.非ST段抬高型心肌梗死患者他汀类药物治疗的早期停药：心肌梗死国家注册研究
Arch Intern Med. 2004 Oct 25;164(19):2162-8. doi: 10.1001/archinte.164.19.2162.
10
Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.首次心血管事件后他汀类药物、β受体阻滞剂和血管紧张素转换酶抑制剂的依从性：一项回顾性队列研究。
Can J Cardiol. 2005 May 1;21(6):485-8.

引用本文的文献

1
Effects of a Secondary Prevention Combination Therapy with beta-Blocker and Statin on Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients.β受体阻滞剂和他汀类药物联合二级预防治疗对急性冠状动脉综合征患者主要不良心血管事件的影响。
Med Sci Monit. 2020 Aug 18;26:e925114. doi: 10.12659/MSM.925114.
2
Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies.基于实验和临床研究对改善心力衰竭治疗的新型治疗靶点的综述。
Ther Clin Risk Manag. 2016 Jun 3;12:887-906. doi: 10.2147/TCRM.S106065. eCollection 2016.
3
Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
口服β受体阻滞剂治疗对Killip 1级心肌梗死患者直接经皮冠状动脉介入治疗后死亡率的影响。
Heart Vessels. 2016 May;31(5):687-93. doi: 10.1007/s00380-015-0673-1. Epub 2015 Apr 12.
4
Adherence to evidence-based secondary prevention pharmacotherapy in patients after an acute coronary syndrome: A systematic review.急性冠状动脉综合征后患者对循证二级预防药物治疗的依从性：一项系统评价。
Heart Lung. 2015 Jul-Aug;44(4):299-308. doi: 10.1016/j.hrtlng.2015.02.004. Epub 2015 Mar 10.
5
Effect of surgical treatment on lipid peroxidation parameters and antioxidant status in the serum of patients with peripheral arterial disease.手术治疗对外周动脉疾病患者血清脂质过氧化参数和抗氧化状态的影响。
Dis Markers. 2013;35(6):647-52. doi: 10.1155/2013/530946. Epub 2013 Nov 3.
6
Statin therapy in heart failure: for good, for bad, or indifferent?他汀类药物在心力衰竭中的应用：是好是坏还是无关紧要？
Curr Atheroscler Rep. 2014 Jan;16(1):377. doi: 10.1007/s11883-013-0377-x.
7
Statins in heart failure: do we need another trial?他汀类药物用于心力衰竭：我们还需要另一项试验吗？
Vasc Health Risk Manag. 2013;9:303-19. doi: 10.2147/VHRM.S44499. Epub 2013 Jun 17.
8
Lipophilic versus hydrophilic statin therapy for heart failure: a protocol for an adjusted indirect comparison meta-analysis.亲脂性与亲水性他汀类药物治疗心力衰竭：一项调整后间接比较荟萃分析的方案。
Syst Rev. 2013 Apr 23;2:22. doi: 10.1186/2046-4053-2-22.
9
Minimizing cardiac risk in perioperative practice - interdisciplinary pharmacological approaches.围手术期心脏风险最小化——多学科药理学方法。
Wien Klin Wochenschr. 2011 Jul;123(13-14):393-407. doi: 10.1007/s00508-011-1595-2. Epub 2011 Jun 22.
10
Effect of beta-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction.β受体阻滞剂对急性心肌梗死后患者心房颤动风险的影响。
Clinics (Sao Paulo). 2010 Mar;65(3):265-70. doi: 10.1590/S1807-59322010000300005.